A new combination of drug therapies may prove effective in treating triple-negative breast cancer in human patients, according to a recent study published by researchers at Harvard Medical School and Baylor College of Medicine.
Stanford University’s Graduate School of Business topped Harvard Business School in U.S. News and World Report’s recently released rankings of the best business schools.
Two new studies by Harvard stem cell labs have shown that human induced pluripotent stem cells (iPSCs) are the equivalent of human embryonic stem cells for the purpose of reconstructing certain key types of cells, including neurons.
Researchers at Harvard Medical School recently discovered a small molecule that may revolutionize the treatment of several neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Creutzfeldt-Jacob.
